ActiveOps FY26 update: revenue up 48%, NRR hits 119%, cash beats forecasts. Growth driven by expansion and Enlighten acquisition.
This article covers information on ActiveOps PLC.
LON:AOMI like this one. ActiveOps has posted a punchy full-year trading update for FY26, with revenue up 48% to £45.0m and Net Revenue Retention (NRR) jumping to 119%. That’s ahead of market expectations on revenue, EBITDA and cash, underpinned by expansion within existing enterprise customers and the mid-year acquisition of Enlighten. It is a clear step up in scale and momentum.
There is a blemish – a contract termination at Enlighten will trim that unit’s ARR trajectory – but the Group has reflected this in reported ARR and expects lower deferred consideration to offset the EPS impact. Overall, execution looks strong, cash generation continues, and the product roadmap is advancing nicely.
| Metric | FY26 (expected) | FY25 | Notes |
|---|---|---|---|
| Revenue | £45.0m (+48%) | £30.5m | Ahead of consensus (£43.0m) |
| Net Revenue Retention (NRR) | 119% (118% CC) | 106% | Upsell and platform migrations drove the jump |
| Organic revenue growth | 28% (31% CC) | 14% | US, Canada and Africa performed particularly well |
| Organic SaaS revenue growth | ~21% (23% CC) | 13% | Solid acceleration |
| Organic Training & Implementation growth | ~81% (86% CC) | 23% | Reflects successful go-lives and migrations |
| Organic ARR | £35.6m (+25%) | £28.4m | 24% CC |
| Group ARR | £41.5m | £30.5m | Includes £5.9m from Enlighten |
| Adjusted EBITDA | ~£4.2m | £2.5m | Ahead of consensus (£3.9m) |
| Exceptional costs | £3.0m | n/a | Enlighten acquisition (£1.8m) and restructuring (£1.2m) |
| Period-end cash | c £23.6m | £20.6m | Ahead of consensus (£17.1m); debt free |
| Users added | c.15,000 | n/a | Onto the Decision Intelligence platform |
| New customers | 9 | 9 | Continued momentum |
Consensus figures are as at 17 April 2026.
The growth mix looks healthy. ActiveOps expanded within existing enterprise accounts, went live with several new customers, and completed the Enlighten acquisition in June 2025. Organically, revenue rose 28% (31% constant currency), with organic SaaS up approximately 21% and Training & Implementation up approximately 81% as implementations and migrations flowed through.
The company highlights strong regional contributions from the US, Canada and Africa. Importantly for scalability, the platform added around 15,000 new users during the year.
NRR measures how much recurring revenue you retain and expand within your existing customer base over a year. At 119% (118% constant currency), ActiveOps is not just holding on to customers – it is selling them more. That’s the engine you want to see in an enterprise SaaS model, and it aligns with the company’s narrative of customers moving up to higher series of the platform to access new AI features, richer reporting and product enhancements.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
24 viewsLikes
No ratings yet
Last updated:
Evidence of upsell momentum is also visible in the migrations: Series 3 now makes up 53% of ControliQ ARR, with Series 4 contributing another 14%. There is a standout data point too – a major customer delivered a 47% ARR uplift after re-signing, having previously indicated it would reduce usage.
ActiveOps acquired Enlighten in Q2 FY26 to deepen its North American and APAC footprint. Since then, it has accelerated the integration timeline, incurring £1.2m of restructuring costs to unlock around £3.0m in annualised savings, with a further £1.0m expected in the coming year. Enlighten contributes £5.9m to Group ARR.
The snag: an Enlighten customer has given notice to terminate, reducing Enlighten ARR for FY27 and FY28 versus prior expectations. This has already been reflected in the Group ARR figure of £41.5m. Because certain contract renewals were tied to deferred consideration, that payment is now expected to fall by approximately £3.5m which, together with contract run-off revenues, means the post-synergy EPS accretion of the deal remains broadly unchanged.
Net-net, while there’s a small drag from the termination, the synergy delivery and lower deferred consideration help steady the financials of the acquisition.
Cash at year-end was approximately £23.6m, up from £20.6m, with the Group remaining debt free. The business also invested £6.4m of cash in the Enlighten acquisition during the year. That’s a tidy balance sheet for a company still investing in growth.
Post period end, ActiveOps sold its trademarks in the UK, US, Australia and EU to the WorkiQ name for USD$10.0m (£7.4m) in cash. No products or customers were sold as part of this transaction. The Board is considering the best use of the capital and will update the market with the full-year results on 2 July 2026. Deployment plans are not disclosed at this stage.
ActiveOps continues to push the product forward. ControliQ Series 3 now represents 53% of ControliQ ARR, with Series 4 at 14%, signalling meaningful adoption of higher-value tiers. Work on ControliQ Series 5 is progressing well, with five Beta customers currently engaged and a broader rollout planned from Summer 2026.
The company positions its Decision Intelligence suite as AI-powered, built on over 20 years of operational data and the AOM methodology. In practice, this is about giving operations leaders the tools to make better, faster decisions that lift productivity and cut backlogs – a message that clearly resonates with large, regulated customers.
Beat on the headline numbers: revenue (£45.0m), adjusted EBITDA (~£4.2m) and cash (c £23.6m) were all ahead of consensus.
High-quality growth signals: NRR at 119% and organic ARR up 25% to £35.6m suggest durable expansion within the base.
Execution and integration: nine new customers, successful go-lives, and accelerated Enlighten synergies (c £3.0m annualised, with another £1.0m targeted) point to good operational control.
Balance sheet strength: debt free, continued cash generation, plus £7.4m cash from the post-period trademark sale.
Watch the Enlighten trajectory: one customer termination reduces expected ARR in FY27-FY28 for that unit, though this is reflected in reported ARR and partly offset by lower deferred consideration.
Visibility on capital allocation: the Board will outline plans for the £7.4m trademark proceeds with results on 2 July 2026.
Management says the strong FY26 close sets up sustained progress in FY27 and beyond, backed by rising relevance of the offering, expansion opportunities within large enterprise customers, and ongoing investment in product and go-to-market. With ControliQ Series 5 nearing broader release and a healthy pipeline of migrations, the ingredients for further upsell are in place.
Mark the diary: full-year results are due on 2 July 2026. Expect detail on capital deployment for the WorkiQ proceeds, an update on Enlighten synergies, and more colour on Series 5 rollout.
Bottom line: this is a confident update. Revenue and earnings are ahead of where the market thought they would be, NRR is excellent, and cash generation continues. The Enlighten wobble is a watch item, but the integration benefits are coming through. For a Decision Intelligence specialist embedded in highly regulated sectors, that’s a solid platform to build on.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.